UTILITY therapeutics
BioTech/Drugs - N/A, N/A, UK
UTILITY therapeutics Employees
UTILITY therapeutics Details
UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.
UTILITY therapeutics Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WP Engine
Tag Management
Google Tag Manager
Hosting
Google Cloud Hosting
Other
Mobile Friendly